Dr. Daniel P. Becker serves as Professor of Chemistry at Loyola University Chicago where his research spans the areas of medicinal chemistry toward the design of therapeutic enzyme inhibitors as antibiotics, supramolecular chemistry in the construction of scaffolds for host-guest chemistry, and new synthetic methodology. Dr. Becker has received accolades for excellence in teaching and mentoring with recognition as a Loyola University Master Teacher Award in 2020 and the Loyola University-wide Hayes Award for Mentoring and Advising in 2015. Prior to joining Loyola University, Dr. Becker served as Project Team Leader at Searle Pharmaceuticals, in Pharmacia and in Pfizer where he was awarded the distinction of Research Fellow.  During his 17 years of industrial pharmaceutical experience he developed treatments for cancer, arthritis, cardiovascular diseases, viral infections, and gastrointestinal disorders.  He has authored 49 publications in medicinal chemistry, synthetic organic methodology, and nanotechnology, and he has been awarded 49 U.S. patents to date for new pharmaceuticals in the therapeutic areas of cancer, arthritis, cardiovascular disease, and gastrointestinal diseases, in addition to new synthetic organic methodology.  Professor Becker earned his B.S. in Chemistry from Kalamazoo College and his Ph.D. in Organic Chemistry from Indiana University.